Argenx Se (ARGX) Assets Average (2016)

Argenx Se (ARGX) posted quarterly Assets Average of $109.5 million for Q4 2016.

Argenx Se (ARGX) Assets Average (2016) Analysis & Trends

Argenx Se (ARGX) has reported Assets Average for 1 consecutive years, with $109.5 million the latest figure, recorded in Q4 2016.

Quarterly Assets Average changed N/A year-over-year to $109.5 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $109.5 million (changed N/A YoY) and the FY2025 annual result came in at $7.4 billion, up 38.53% from the prior year.
Assets Average was little changed at $109.5 million in Q4 2016 per ARGX's latest filing.
Over the last five years, Assets Average for ARGX reached as high as $109.5 million in Q4 2016 and fell as low as $109.5 million in Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets Avg. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	303.40 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	65.01 Mn
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	8.37 Bn
4	NuCana	279.75 Bn	279.75 Bn	-	41.64 Mn
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	26.06 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	40.71 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	795.91 Mn
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	2.30 Bn
10	Alnylam Pharmaceuticals	35.71 Bn	32.70 Bn	959.66 Mn	5.05 Bn

Download Data

Date	Value
Dec 31, 2016	109.49 Mn